Executive vice president of research and development, Sean Harper, has announced his retirement from Amgen.
Harper joined Amgen in 2012, and has since held varying positions within the company, including vice president of development, and vice president of global regulatory affairs and safety.
“…This was, of course, an exceedingly difficult life decision for me, given the wonderful experience I’ve had over more than 16 years at Amgen,” said Harper during an investor call last week.
“I love the mission, the people, the science and technology. That said, it’s rare in our industry to have the opportunity to personally hire from academia and develop over more than a dozen years, such a capable individual as David Reese as a successor for head of R&D,” he added.
Prior to joining Amgen, Harper held the position of senior director of clinical genomics at Merck Research Laboratories. Harper studied medicine at the University of California in San Francisco, and completed a postdoctoral fellowship at the Massachusetts Institute of Technology.